New allergy tablets offer alternative to shots

Your Health Matters

This product image provided by Merck shows the packaging for newly FDA-approved allergy medications Grastek, left, and Ragwitek. Grastek is used in the treatment of diagnosed Timothy grass pollen induced allergic rhinitis, with or without conjunctivitis, in adults and children 5 years of age and older. Ragwitek is indicated as immunotherapy for diagnosed ragweed pollen induced allergic rhinitis, with or without conjunctivitis, in adults 18 years of age and older. (AP Photo/Merck)TRENTON, N.J. (AP) — For decades, seasonal allergy sufferers had two therapy options to ease the misery of hay fever. They could swallow pills or squirt nasal sprays every day for brief reprieves from the sneezing and itchy eyes. Or they could get allergy shots for years to gradually reduce their immune system's over-reaction.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave